Scientists now have an encouraging lead on a coronavirus treatment after borrowing a page from prostate cancer. Two proteins — TMPRSS2 and ACE2 — assist the coronavirus in accessing an individual’s body and multiplying within the body’s cells. Arul Chinnaiyan, who is director of the Michigan Center for Translational Pathology, is familiar with the TMPRSS2 protein, seeing as it was his lab that discovered that the protein merges with the ETS gene to cause a majority of the prostate cancers. The researchers at the lab were also aware that the androgen receptor regulated the TMPRSS2 protein.
Earlier this year, Chinnaiyan’s laboratory turned its mind and attention to the coronavirus. The group of researchers utilized…
NOTE TO INVESTORS: The latest news and updates relating to MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) are available in the company’s newsroom at https://ibn.fm/MGROF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork.